These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4072875)

  • 1. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cibenzoline for high-frequency ventricular arrhythmias: a short-term comparison with quinidine and a long-term follow-up.
    Palakurthy PR; Maldonado C; Sohi G; Flowers NC
    J Clin Pharmacol; 1987 Apr; 27(4):283-7. PubMed ID: 3680585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E; Mattke S; Haberl R; Steinbeck G
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.
    Kostis JB; Krieger S; Moreyra A; Cosgrove N
    J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term antiarrhythmic therapy with cibenzoline.
    Mohiuddin SM; Hilleman DE; Esterbrooks D; Mooss AN; Stengel LA
    J Clin Pharmacol; 1987; 27(5):400-6. PubMed ID: 3693585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dosing interval and optimum dose of cibenzoline.
    Zempol P; Aogaichi K; Butler B; Tepper D; Somberg JC
    J Clin Pharmacol; 1987 Sep; 27(9):666-72. PubMed ID: 3680596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral cibenzoline for ventricular arrhythmias.
    Klein RC; Horwitz LD; Rushforth N
    Am J Cardiol; 1986 Mar; 57(8):592-7. PubMed ID: 3953445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study.
    Lee MA; Fenster PE; Garcia ZM; Kipps JE; Huang SK
    Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.
    Harron DW; Brogden RN; Faulds D; Fitton A
    Drugs; 1992 May; 43(5):734-59. PubMed ID: 1379150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog.
    Keren G; Tepper D; Butler B; Miura D; Aogaichi K; Somberg J
    J Clin Pharmacol; 1984 Oct; 24(10):466-72. PubMed ID: 6511989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):148-53. PubMed ID: 2435991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral cibenzoline in arrhythmia patients.
    Brazzell RK; Colburn WA; Aogaichi K; Szuna AJ; Somberg JC; Carliner N; Heger J; Morganroth J; Winkle RA; Block P
    Clin Pharmacokinet; 1985; 10(2):178-86. PubMed ID: 3995859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.